Skip to main content
. 2021 Sep 24;50:661–669. doi: 10.1016/j.ajem.2021.09.050

Table 1.

Study characteristics and quality assessment

Study ID Year Setting Study design Patients with COVID-19 (M/F) Age (median and range) (AF vs no AF) ORs NOS score (S C O)
Peltzer et al. [22] 2020 Multicenter, USA Retrospective 1053 (653/400) 74.5 (± 13.0) vs 60.1 (± 17.0) Adjusted 3 2 3
Rodilla et al. [23] 2020 Multicenter, Span Retrospective 12,226 (7018/5208) 67.5 ± 16.1 (overall) Adjusted 3 2 1
Inciardi et al. [8] 2020 Single center, Italy Retrospective 99 (80/19) 67 ± 12 (overall) Unadjusted 3 0 3
Russo et al. [16] 2020 Multicenter, Italy Retrospective 414 (253/161) 65.5 (± 15.5) vs 73.7 (± 9.9) Unadjusted 3 1 3
Bhatla et al. [24] 2020 Single center, USA Retrospective 700 (314/386) N/A Unadjusted 3 0 3
Yamada et al. [25] 2020 Multicenter, USA Retrospective 210 (N/A) N/A Unadjusted 1 1 3
Atkins et al. [26] 2020 Multicenter, UK Retrospective 507 (311/196) 74.3 ± 4.5 (overall) Adjusted 2 2 3
Quisi et al. [27] 2020 Multicenter, Turkey Retrospective 349 (153/196) N/A Unadjusted 3 1 3
Elias et al. [28] 2020 Multicenter, USA Retrospective 1258 (685/573) 61.6 ± 18.4 (overall) Adjusted 2 2 3
Wang et al. [29] 2020 Multicenter, China Retrospective 319 (152/167) 64.97 ± 13.15 (overall) Adjusted 3 2 2
Reilev et al. [30] 2020 Multicenter, Denmark Retrospective 11,122 (4693/6429) N/A Unadjusted 3 1 1
Gerwen et al. [15] 2020 Single center, USA Retrospective 3703 (2048/1655) 56.8 ± 18.2 (overall) Adjusted 3 2 2
Peterson et al. [14] 2020 Single center, USA Retrospective 355 (181/174) 66.21 ± 14.21 (overall) Adjusted 2 2 3
Mccullough et al. [31] 2020 Single center, USA Retrospective 754 (478/278) 63.3 ± 16.0 (overall) Adjusted 3 2 2
Ghio et al. [32] 2020 Single center, Italy Prospective 405 (278/127) N/A Unadjusted 2 1 3
Li et al. [33] 2020 Single center, China Prospective 113 (68/45) 67.3 ± 14.1 (overall) Unadjusted 3 1 1
Rodríguez-Molinero et al. [34] 2020 Multicenter, Span Retrospective 418 (238/180) 65.4 ± 16.6 (overall) Adjusted 2 2 1
Clift et al. [35] 2020 Multicenter, UK Prospective 6,083,102 (3,035,409/3047693) N/A Unadjusted 3 1 2
Shah et al. [36] 2020 Single center, USA Retrospective 487 (N/A) 68.42 ± 16.70 (overall) Unadjusted 3 1 1
Lano et al. [37] 2020 Multicenter, France Retrospective 122 (79/43) 73.5 (64.2–81.2) Unadjusted 3 1 1
Polverino et al. [38] 2020 Multicenter, Italy Retrospective 3179 (2171/1008) 69.0 (57–78) Unadjusted 3 1 1
Izurieta et al. [39] 2020 Multicenter, USA Retrospective 25,333,329 (N/A) N/A Adjusted 2 2 1
Gue et al. [40] 2020 Single center, UK Retrospective 316 (188/128) N/A Adjusted 3 2 2
Perez-Guzman et al. [41] 2020 Multicenter, UK Retrospective 614 (382/232) 69 ± 25 (overall) Adjusted 3 2 1
Canevelli et al. [42] 2020 Multicenter, Italy Retrospective 415 (219/196) 84.3 ± 8.1 (overall) Adjusted 2 2 3
Rossi et al. [43] 2020 Multicenter, Italy Retrospective 590 (399/191) 76.2 (68.2–82.6, overall) Unadjusted 3 0 2
Alvarez-Garcia et al. [44] 2020 Multicenter, USA Retrospective 6439 (3547/2892) 63.5 ± 18 (overall) Adjusted 2 2 2
Spinoni et al. [9] 2021 Multicenter, Italy Retrospective 637 (N/A) N/A Adjusted 3 2 1
Özdemir et al. [12] 2021 Single center, Turkey Retrospective 350 (194/156) 76 (64–82) vs 51 (37–65) Unadjusted 4 1 2
Sanz et al. [13] 2021 Single center, Spain Prospective 160 (96/64) 75.9 (± 9.6) vs 64.9 (± 16.3) Unadjusted 4 1 1
Mountantonakis et al. [10] 2021 Multicenter, USA Retrospective 2476 (1551/925) 73.1 (± 13.5) vs 73.6 (± 13.3) Unadjusted 3 2 1
Poterucha et al. [45] 2021 Multicenter, USA Retrospective 887 (N/A) N/A Unadjusted 3 0 1
García-Granj et al. [46] 2021 Single center, Span Retrospective 517 (290/227) 81.6 (± 8.7) vs 66.5 (± 14.9) Unadjusted 3 1 1
Kelesoglu et al. [47] 2021 Single center, Turkey Retrospective 658 (372/286) 54 ± 14 (overall) Unadjusted 3 1 1
Denegri et al. [48] 2021 Single center, Italy Retrospective 201 (N/A) N/A Adjusted 3 2 1
Zylla et al. [11] 2021 Multicenter, Germany Retrospective 166 (108/58) 64.1 ± 16.7 (overall) Unadjusted 3 1 1

COVID-19: coronavirus disease 2019; M/F: Male/Female; AF: atrial fibrillation; OR: odds ratio; NOS: Newcastle-Ottawa scale; S: selection; C: comparability; O: outcome; N/A: not available.